BPC 157 Cost: What You Need to Know Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Peptides like BPC 157 and Retatrutide are not FDA approved! Check out the link below to learn more. If you're on these drugs, please be careful!, https: www.safehg.com fdas overreach on compounded pe